A New Antibiotic Weakness—Drugs Themselves Help Bacteria Survive

Antibiotics save lives, but they are not fail-safe. Even when microbes haven’t acquired drug-evading genetic mutations—a hallmark of antibiotic resistance—the medications don’t always clear infections. A new study identifies a surprising reason why: At infection sites, antibiotics change the natural mixture of chemicals made by the body in ways that protect infecting bacteria. They also […]


On September 13, 2017 researchers from the Massachusetts Institute of Technology and the University of Massachusetts Medical School simultaneously published papers in Nature on the same intriguing topic: a link between autism and infection during pregnancy.

Gut bacteria could determine whether you develop PTSD

Molecular Biologists found that you’re more likely to develop PTSD if you lack in certain immune supporting bacteria

Gut microbes could help trigger multiple sclerosis

The trillions of bacteria that live in our intestines, known collectively as the gut microbiome, have been linked to maladies from eye disease to rheumatoid arthritis. Now, two new studies have added another disease: multiple sclerosis (MS)

The Next Big Performance Enhancing Drug: Bacteria From Elite Athletes’ Guts?

When Jonathan Scheiman describes his lab as “a lot of crazy shit,” he’s not kidding. For the last three years, the 35-year-old molecular biologist has been working at Harvard University studying the, um, stool of pro marathoners, ultra- runners, and Olympic rowers.

Two new studies support the link between the gut microbiome and multiple sclerosis

Previous research has found that multiple sclerosis (MS) patients may have a specific microbial signature in their gut microbiota that could impact disease pathogenesis.

Global Human Microbiome Market Size and Forecast to 2021

Description: Human Microbiome Report by Material, Application, and Geography — Global Forecast to 2021 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

Enterome’s EB8018, a First-in-class Drug Candidate Targeting Crohn’s Disease, Successfully Completes Phase I Study in Healthy Volunteers

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce the successful completion of the first Phase 1 clinical study with its lead candidate EB8018, a small molecule designed to block FimH, as a potential new orally-administered treatment for Crohn’s disease.

Scientists investigate the ‘black box’ of bacterial effects on the brain and behaviour

Researchers from McMaster University (Canada) had a clear question in mind when they conducted their recent experiment: if a mouse had its gut microbiota altered by antibiotics in early life, what would happen to its brain?

How gut bacteria saved ‘dirty mice’ from death

Even if you’re a clean freak, it’s hard to escape a decade of discoveries that some of the microbes naturally residing in your body—your microbiome—help keep you healthy.

Intestinal inflammation induced by oral bacteria

An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders.

Faster metabolism makeover—nurturing your gut bacteria

Here’s how to take control of your cravings and lose weight for good by improving your gut health.

Evidence found of oral bacteria contributing to bowel disorders

An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders.

One More Small Piece of the Puzzle on the Role of Gut Micro-organisms in MS

Researchers found a significant increase in some types of gut bacteria and lower levels of an anti-inflammatory factor in untreated multiple sclerosis twins.

Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection

Highlights •Pipeline for hybrid equation based and machine learning disease modeling used to predict efficacy of novel therapeutics against Clostridium difficile infection.

Modeling and Artificial Intelligence Systems For Accelerating Drug Development

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) has developed a computational pipeline to test and predict the efficacy of existing and novel treatments against Clostridium difficile infection (CDI). The research study is published within Artificial Intelligence in Medicine.

Cesarean Section Results in Heavier Mouse Pups

Vaginal birth leads to changes in the development of offsprings’ microbiomes not seen among mice born via C-section, which researchers suspect might contribute to the weight differences.

Scientists Generate 3D Map of Gut Microbiome

Scientists have generated a rudimentary map of the human gut microbiome, which shows the spatial organization of different microbial species.

Study shows stress could be just as unhealthy as junk food

We all know that a poor diet is unhealthy, but a new BYU study finds that stress may just as harmful to our bodies as a really bad diet.

Engineering The Microbiome – The Next Frontier

Microbial ecology, our understanding of what determines the robustness and community dynamics of microbial consortia, and synthetic biology,

Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required

Terms & Conditions | Privacy Policy | © 2016 The Translational Microbiome Research Forum